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Weather-related disasters increasing
An international team reporting in The Lancet say that climate 
change is already having a significant effect on health. This because 
of an increase in the number of weather-related disasters, greater 
exposure to heatwaves and an increased risk of dengue fever because 
conditions are more favourable for mosquitoes. 
A key underpinning assumption is that the rise in temperatures 
where people live is much higher than the average increase in global 
temperature as a whole, because land warms to a greater extent 
than do oceans. This means that the number of people exposed to 
heatwaves rose by 125 million between 2000 and 2016. Between 2007 
and 2016, weather-related disasters increased by 46% compared with 
the 1990 - 1999 average, with most deaths occurring in resource-poor 
countries. 
Watts N, Amann M, Ayeb-Karlsson S, et al. The Lancet countdown on health and climate change: from 25 
years of inaction to a global transformation for public health. Lancet 2017 (epub 30 October 2017). http://
dx.doi.org/10.1016/S0140-6736(17)32464-9
Still gaps in yellow fever vaccination 
cover
Recent large outbreaks of yellow fever in Angola and Brazil in the 
past 2 years, combined with global shortages in vaccine stockpiles, 
highlight a pressing need to assess present control strategies. A study 
published in the The Lancet Infectious Diseases estimated global 
yellow fever vaccination coverage from 1970 through to 2016 to 
calculate the number of individuals still needing vaccination in order 
to reach the thresholds for outbreak prevention.
The authors found major increases in vaccine coverage since 
1970, but with notable gaps within yellow fever risk zones, with 
an estimated 393.7 million to 472.9 million people who still need 
vaccination in yellow fever risk zones to reach the 80% coverage 
recommended by the World Health Organization. 
Shearer FM, Moyes CL, Pigott DM, et al. Global yellow fever vaccination coverage from 1970 to 2016: An 
adjusted retrospective analysis. Lancet Infect Dis 2017;17(11):1209-1217. https://doi.org/10.1016/S1473-
3099(17)30419-X
Stents for stable angina of no benefit
Percutaneous coronary intervention (PCI) is not significantly 
better than a placebo procedure in improving exercise capacity 
or symptoms, even in patients with severe coronary stenosis, 
according to the ORBITA study published in The Lancet. This is the 
first double-blind randomised controlled trial to directly compare 
stenting with placebo in patients with angina who are receiving the 
correct drug treatment.
Exercise tests were carried out before the procedure and 6 weeks 
later in 200 patients with severe (≥70%) single-vessel stenosis, who 
had been given 6 weeks of intensive medical treatment and were 
then randomly assigned to PCI (105 patients) or a placebo group 
(95  patients). The placebo group only had an angiogram. There 
was no statistically significant difference in overall exercise time or 
symptom alleviation before and after the procedure between the two 
groups. 
Al-Lamee R, Thompson D, Dehbi H, et al. Percutaneous coronary intervention in stable angina (ORBITA): 
A double blind, randomised controlled trial. Lancet 2017 (epub 2 November 2017). https://doi.org/10.1016/
S0140-6736(17)32714-9
Misdiagnosis of type 3 diabetes
A large primary care study in the UK has found that type 3 diabetes, 
or diabetes of the exocrine pancreas, is commonly misdiagnosed as 
type 2 diabetes in most patients.
Researchers used routinely collected primary care records for 
more than 2 million patients in England for incident cases of 
adult-onset diabetes between 1 January 2005 and 31 March 2016. 
In results reported in Diabetes Care, they identified 31 789 new 
diagnoses of adult-onset diabetes. They found 559 cases of diabetes 
that occurred after pancreatic disease. Doctors treating these cases 
generally classified them as type 2 diabetes (87.8%), with only 2.7% 
of cases being classified as diabetes of the exocrine pancreas. 
Compared with patients with type 2 diabetes, patients with 
diabetes occurring after pancreatic disease were nearly twice as likely 
to have poor glycaemic control and much more likely to need insulin 
within 5 years of diagnosis.
Woodmansey C, McGovern AP, McCullough KA, et al. Incidence, demographics, and clinical characteristics 
of diabetes of the exocrine pancreas (type 3c): A retrospective cohort study. Diabetes Care 2017;40(11):1486-
1493. https://doi.org/10.2337/dc17-0542
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